Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols

Human Reproduction

Volumn 21, Issue 10, 2006, Pages 2593-2600

  Lossl, Kristine ^a   Andersen, A N ^a   Loft, A ^a   Freiesleben, N L C ^a   Bangsboll S ^a   Andersen, C Yding ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Androgen priming; Aromatase inhibitor; Follicular fluid; GnRH antagonist; Ovarian stimulation

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; CETRORELIX; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG USE; FEMALE; FOLLICULAR PHASE; HORMONE SENSITIVITY; HUMAN; HUMAN EMBRYO; NIDATION; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TABLET; TESTOSTERONE BLOOD LEVEL;

EID: 33749591314     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del221     Document Type: Article

References (22)

1. Al-Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 17,874-885.
2. Andersen CY (1993) Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 77,1227-1234.
3. Biljan MM, Hemmings R and Brassard N (2005) The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 84(Suppl. 1), S64-S65.
4. Casper RF and Mitwally MF (2005) Aromatase inhibitors for ovulation induction. Reprod Biol Endocrinal 3,54.
5. Chadha S, Pache TD, Huikeshoven JM, Brinkmann AO and van der Kwast TH (1994) Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. Hum Pathol 25,1198-1204.
6. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A and Pellicer A (2005) The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot study. Fertil Steril 84,82-87.
7. Hild-Petito S, West NB, Brenner RM and Stouffer RL (1991) Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biol Reprod 44,561-568.
8. Hillier SG, Tetsuka M and Fraser HM (1997) Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod 12,107-111.
9. Hohmann FP, Laven JS, de Jong FH and Fauser BC (2005) Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women. Eur J Endocrinol 152,395-401.
10. Horie K, Takakura K, Fujiwara H, Suginami H, Liao S and Mori T (1992) Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum Reprod 7,184-190.
11. Iwase A, Ando H, Kuno K and Mizutani S (2005) Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization. Obstet Gynecol 105,645-652.
12. Ludwig M, Katalinic A and Diedrich K (2001) Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 265,175-182.
13. Mannaerts BM, Geurts TB and Odink J (1998) A randomized three-way crossover study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration. Hum Reprod 13,1461-1464.
14. McNatty KP, Smith DM, Makris A, Osathanondh R and Ryan KJ (1979) The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49,851-860.
15. Mitwally MF, Casper RF and Diamond MP (2005) The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment. Reprod Biol Endocrinol 3,54.
16. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81,19-25.
17. Staessen C, Camus M, Khan I, Van Smitz JWL, Wisanto A, Devroey P and Van Steirteghem AC (1989) An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos. J In Vitro Fert Embryo Transf 6,22-29.
18. Vendola KA, Zhou J, Adesanya OO, Weil SJ and Bondy CA (1998) Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101,2622-2629.
19. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J and Bondy CA (1998) Androgen receptor gene expression in the primate ovary, cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83,2479-2485.
20. Weil S, Vendola K, Zhou J and Bondy CA (1999) Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84,2951-2956.
21. Ziebe S, Petersen K, Lindenberg S, Andersen AG, Gabrielsen A and Andersen AN (1997) Embryo morphology or cleavage stage: How to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 12,1545-1549.
22. de Ziegler D (2003) The dawning of the non-cancer uses of aromatase inhibitors in gynaecology. Hum Reprod 18,1598-1602.